Marta Larráyoz
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Luis M. Montuenga (7 shared papers)Rubén Pı́o (7 shared papers)Jackeline Agorreta (7 shared papers)Jonathan C. Strefford (9 shared papers)Andrew J. Steele (9 shared papers)Francesco Forconi (6 shared papers)Graham Packham (6 shared papers)Mark S. Cragg (6 shared papers)
- Journals
- Blood (5 papers)Leukemia (2 papers)Molecular Cancer (1 paper)Molecular & Cellular Proteomics (1 paper)EMBO Molecular Medicine (1 paper)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Marta Larráyoz
17 papers receiving 684 citations
Peers
Comparison fields: 5 of 62
- Genetics 200
- Geriatrics and Gerontology 49
- Immunology 163
- Pathology and Forensic Medicine 129
- Oncology 164
Countries citing papers authored by Marta Larráyoz
This map shows the geographic impact of Marta Larráyoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Larráyoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Larráyoz more than expected).
Fields of papers citing papers by Marta Larráyoz
This network shows the impact of papers produced by Marta Larráyoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Larráyoz. The network helps show where Marta Larráyoz may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Larráyoz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 83 | |
| 2 | 2016 | 70 | |
| 3 | 2014 | 65 | |
| 4 | 2015 | 65 | |
| 5 | 2012 | 64 | |
| 6 | 2010 | 62 | |
| 7 | 2016 | 57 | |
| 8 | 2016 | 47 | |
| 9 | 2018 | 46 | |
| 10 | 2016 | 42 | |
| 11 | 2015 | 34 | |
| 12 | 2016 | 23 | |
| 13 | 2014 | 19 | |
| 14 | 2021 | 5 | |
| 15 | 2015 | 3 | |
| 16 | 2023 | 2 | |
| 17 | The contribution of gene mutations to long-term clinical outcomes: data from the randomised UK LRF CLL4 trial | 2017 | 2 |
About Marta Larráyoz
Marta Larráyoz is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Oncology and Molecular Biology, having authored 17 papers that have together received 689 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Genetics (200 citations), Geriatrics and Gerontology (49 citations), Immunology (163 citations), Pathology and Forensic Medicine (129 citations) and Oncology (164 citations). Marta Larráyoz has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Luis M. Montuenga, Rubén Pı́o, Jackeline Agorreta, Jonathan C. Strefford, Andrew J. Steele, Francesco Forconi, Graham Packham, Mark S. Cragg, Matthew D. Blunt and Rachel Dobson. Their work appears in journals such as Blood, Leukemia, Molecular Cancer, Molecular & Cellular Proteomics and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.